The Psychiatric drug development landscape is at an inflection point, with emerging mechanisms and innovative technologies promising to shape the future of Psychiatric therapeutics.
We are pleased to invite you to our exclusive Beacon Psychiatric fireside chat, where we’ll explore the scientific advancements driving the next wave of innovation, with one of the fields leading voices, Dr. Jacinthe Gingras, Chief Scientific Officer at Perpetual Bio.
This thought-provoking session will uncover which mechanisms and technologies look set to transform Psychiatric drug development in 2026 and beyond.
Key Insights:
- Schizophrenia: Discover life beyond dopamine, as we discuss non-dopamine anti-psychotics.
- Depression: Novel mechanisms of action, including the benefits of targeting NMDA receptor signaling.
- PTSD & Stress Disorders: The opportunities and challenges for psychedelic-based therapies.
- Addiction: The potential of GLP-1 as a novel target to treat alcohol and nicotine addiction.
- Emerging Technologies: Advancements in blood brain barrier-crossing & CNS delivery platforms, as well as the potential of digital wearables as clinical trial endpoints.
About The Speaker:
Dr. Jacinthe Gingras has 30 years’ experience in Neuroscience’s, having built numerous Neuroscience portfolios, and led large departments in progressing therapeutic programs from early discovery through to IND approval.
This session offers a rare opportunity to hear directly from Dr. Gingras, as she explores the key advancements driving innovation in Psychiatric drug development
Webinar Leaders
Jacinthe Gingras
Chief Scientific Officer,
Perpetual Bio
You May Also Be Interested In…
Learn More About Psychiatric
- The Most Comprehensive Way to Search the Psychiatric Drug Development Landscape: Unique search ontologies based on Psychiatric drug and trial characteristics
- Market Leading Approach to Psychiatric Preclinical & Clinical Data Curation: Manual curation of key Psychiatric research and development data points by Psychiatric research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Psychiatric company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
